tetano
Editor, Senior Moderator
Life (Basel)
. 2022 Aug 27;12(9):1326.
doi: 10.3390/life12091326.
Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China
Jinze Dong[SUP] 1 [/SUP], Yong Zhou[SUP] 1 [/SUP], Juan Pu[SUP] 1 [/SUP], Litao Liu[SUP] 1 [/SUP]
Affiliations
Abstract
In China, H9N2 avian influenza virus (AIV) has become widely prevalent in poultry, causing huge economic losses after secondary infection with other pathogens. Importantly, H9N2 AIV continuously infects humans, and its six internal genes frequently reassort with other influenza viruses to generate novel influenza viruses that infect humans, threatening public health. Inactivated whole-virus vaccines have been used to control H9N2 AIV in China for more than 20 years, and they can alleviate clinical symptoms after immunization, greatly reducing economic losses. However, H9N2 AIVs can still be isolated from immunized chickens and have recently become the main epidemic subtype. A more effective vaccine prevention strategy might be able to address the current situation. Herein, we analyze the current status and vaccination strategy against H9N2 AIV and summarize the progress in vaccine development to provide insight for better H9N2 prevention and control.
Keywords: H9N2 AIV; antigenicity; influenza virus; vaccine.
. 2022 Aug 27;12(9):1326.
doi: 10.3390/life12091326.
Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China
Jinze Dong[SUP] 1 [/SUP], Yong Zhou[SUP] 1 [/SUP], Juan Pu[SUP] 1 [/SUP], Litao Liu[SUP] 1 [/SUP]
Affiliations
- PMID: 36143363
- DOI: 10.3390/life12091326
Abstract
In China, H9N2 avian influenza virus (AIV) has become widely prevalent in poultry, causing huge economic losses after secondary infection with other pathogens. Importantly, H9N2 AIV continuously infects humans, and its six internal genes frequently reassort with other influenza viruses to generate novel influenza viruses that infect humans, threatening public health. Inactivated whole-virus vaccines have been used to control H9N2 AIV in China for more than 20 years, and they can alleviate clinical symptoms after immunization, greatly reducing economic losses. However, H9N2 AIVs can still be isolated from immunized chickens and have recently become the main epidemic subtype. A more effective vaccine prevention strategy might be able to address the current situation. Herein, we analyze the current status and vaccination strategy against H9N2 AIV and summarize the progress in vaccine development to provide insight for better H9N2 prevention and control.
Keywords: H9N2 AIV; antigenicity; influenza virus; vaccine.